BROWSE

Related Researcher

Author's Photo

Cho, Yoon-Kyoung
Integrated Nano-Biotech Lab (INBL)
Research Interests
  • Microfluidics, Lab-on-a-chip, personalized biomedical diagnostics, nanobioengineering

ITEM VIEW & DOWNLOAD

Circulating Tumor Cells and TWIST Expression in Patients with Metastatic Gastric Cancer: A Preliminary Study

DC Field Value Language
dc.contributor.author Jhi, Joon Hyung ko
dc.contributor.author Kim, Gwang Ha ko
dc.contributor.author Park, Su Jin ko
dc.contributor.author Kim, Dong Uk ko
dc.contributor.author Lee, Moon Won ko
dc.contributor.author Lee, Bong Eun ko
dc.contributor.author Kwon, Chae Hwa ko
dc.contributor.author Cho, Yoon-Kyoung ko
dc.date.available 2021-11-04T07:35:42Z -
dc.date.created 2021-10-29 ko
dc.date.issued 2021-10 ko
dc.identifier.citation JOURNAL OF CLINICAL MEDICINE, v.10, no.19, pp.4481 ko
dc.identifier.issn 2077-0383 ko
dc.identifier.uri https://scholarworks.unist.ac.kr/handle/201301/54755 -
dc.description.abstract Background and Aims: The clinical significance of circulating tumor cells (CTCs) and TWIST expression in CTCs remains unelucidated in patients with gastric cancer (GC). Here, we evaluated CTCs and TWIST expression in CTCs and explored their correlation with prognosis in patients with metastatic GC. Methods: Peripheral blood samples were prospectively obtained from 31 patients with metastatic GC between September 2017 and December 2018, prior to treatment. CTCs were detected using a centrifugal microfluidic system and CTCs positive for TWIST immunostaining were defined as TWIST (+) CTCs. Results: CTCs and TWIST (+) CTCs were detected in 25 (80.6%) and 24 (77.4%) of the 31 patients, respectively. CTC count in patients with first diagnosis of metastatic cancer tended to be higher than that in those with recurrent metastatic cancer, but TWIST (+) CTC count was not different between the two groups. There was no difference in CTC and TWIST (+) CTC counts according to histopathologic type, peritoneal dissemination, hematogenous metastasis, serum tumor makers, or response to first-line chemotherapy. Patients with CTCs > 7.5/7.5 mL of blood showed shorter overall survival (OS) than those with CTCs & LE; 7.5/7.5 mL of blood (p = 0.049). Additionally, patients with TWIST (+) CTCs > 2.5/7.5 mL of blood tended to show shorter OS than those with TWIST (+) CTCs & LE; 2.5/7.5 mL of blood (p = 0.105). Conclusions: Our study demonstrated that high levels of CTCs and TWIST (+) CTCs were associated with worse OS. ko
dc.language 영어 ko
dc.publisher MDPI ko
dc.title Circulating Tumor Cells and TWIST Expression in Patients with Metastatic Gastric Cancer: A Preliminary Study ko
dc.type ARTICLE ko
dc.identifier.scopusid 2-s2.0-85115949268 ko
dc.identifier.wosid 000708261400001 ko
dc.type.rims ART ko
dc.identifier.doi 10.3390/jcm10194481 ko
dc.identifier.url https://www.mdpi.com/2077-0383/10/19/4481 ko
Appears in Collections:
BME_Journal Papers

find_unist can give you direct access to the published full text of this article. (UNISTARs only)

Show simple item record

qrcode

  • mendeley

    citeulike

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

MENU